Live attenuated varicella vaccine: Protection in healthy adults compared with leukemic children

Journal of Infectious Diseases

Volumn 161, Issue 4, 1990, Pages 661-666

  Gershon, Anne A ^a   Steinberg, Sharon R ^a   Ahronheim, Gerald ^b   Andiman, Warren ^c   Arvin, Ann ^d   Brown, Arthur E ^e   Castleberry, Robert ^f   Chartrand, Stephen ^g   Congeni, Blaise ^h   Dennehy, Penelope ⁱ   Dunn, Nancy ^j   Maurer, Harold ^j   LaRussa, Philip ^a   Garvin, James ^a   Faden, Howard ^k   Gelb, Lawrence ^l   Land, Vita ^l   Hammerschlag, Margaret ^m   Hutter, John ⁿ   Kochen, Joseph ^o   Law, Barbara ^p   Lepow, Martha ^q   Leventhal, Brigid ^r   Levin, Myron ^s   Marks, Melvin ^t   Rettig, Philip ^t   Mauer, Helen ^u   Stockman, James ^u   Ragab, Abdel ^v   Ross, Avron ^w   Sallan, Stephen ^x   Sartain, Peggy ^y   Shah, Narayan ^z   Stutman, Harris ^aa   Truman, John ^ab   Tufenkeji, Haysam ^ac   Wallenberg, Joyce ^ac   Weiner, Michael ^ad   Vats, Tribhawan ^ae   Zaia, John ^af   Weiner, Leonard ^ag   Zoger, Seymour ^ah   more..

^a College of Physicians and Surgeons ^*  (United States)

^b UNIVERSITY OF MONTREAL   (Canada)

^c YALE UNIVERSITY   (United States)

^d STANFORD UNIVERSITY   (United States)

^e Memorial Hospital   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g UNIVERSITY OF SOUTH ALABAMA   (United States)

^h AKRON CHILDREN'S HOSPITAL   (United States)

ⁱ RHODE ISLAND HOSPITAL   (United States)

^j VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^k CHILDREN S HOSPITAL OF BUFFALO   (United States)

^l WASHINGTON UNIVERSITY   (United States)

^m SUNY DOWNSTATE MEDICAL CENTER   (United States)

ⁿ UNIVERSITY OF ARIZONA   (United States)

^o NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^p CHILDREN S HOSPITAL RESEARCH INSTITUTE OF MANITOBA   (Canada)

^q ALBANY MEDICAL CENTER   (United States)

^r JOHNS HOPKINS UNIVERSITY   (United States)

^s UNIVERSITY OF COLORADO   (United States)

^t UNIVERSITY OF OKLAHOMA   (United States)

^u CHILDREN'S MEMORIAL HOSPITAL   (United States)

^v EMORY UNIVERSITY   (United States)

^w NASSAU UNIVERSITY MEDICAL CENTER   (United States)

^x DANA FARBER CANCER INSTITUTE   (United States)

^y UNIVERSITY OF TEXAS AT DALLAS   (United States)

^z GEISINGER MEDICAL CENTER   (United States)

^aa MILLER CHILDREN S HOSPITAL   (United States)

^ab MASSACHUSETTS GENERAL HOSPITAL   (United States)

^ac Division of Virology Department of Infectious Diseases St Jude Children's Hospital   (United States)

^ad MOUNT SINAI HOSPITAL   (United States)

^ae UNIVERSITY OF KANSAS   (United States)

^af CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^ag SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^ah UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VACCINE;

ARTICLE; CELLULAR IMMUNITY; CHICKENPOX; DRUG DOSE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; INFECTION RATE; LEUKEMIA; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VACCINATION;

ADULT; ANTIBODIES, VIRAL; CHICKENPOX; CHICKENPOX VACCINE; CHILD; COMPARATIVE STUDY; HERPESVIRUS 3, HUMAN; HUMAN; IMMUNITY, CELLULAR; LEUKEMIA; REGRESSION ANALYSIS; VACCINES, ATTENUATED; VIRAL VACCINES;

EID: 0025318162     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/161.4.661     Document Type: Article

References (20)

1. Takahashi M., Otsuka T., Okuno Y., Asano Y., Yazake T., Isomura S. Livevaccine used to prevent the spread of varicella in children in hospital. Lancet 1974;2:1288–1290 ’
2. Izawa T., Ihara T., Hattori A., Iwasa T., Kamiya H., Sakurai M., Takahashi M. Application of a live varicella vaccine in children with acute leukemia or other malignant diseases. Pediatrics 1977;60:805–809
3. Weibel R.E., Nef F.B.J., Kuter B.J., Guess H.A., Rotherberger C.A., Fitzgerald A.J., Connor K.A., McLean A.A., Hilleman M.R., Buynak E.B., Scolnick E.M. Live attenuated varicella virus vaccine: Efficacy trial in healthy children. N Engl J Med 1984;310:1409–1415
4. Gershon A.A., Steinberg S.P., LaRussa P., Ferrara A., Hammerschlag M., Gelb L., The NLAID Varicella Vaccine Collaborative Study Group. Immunization of healthy adults with live attenuated varicella vaccine. J Infect Dis 1988;158:132–137
5. Gershon A.A., Steinberg S.P., Gelb L., Galasso G., Borkowsky W., LaRussa P., Ferrara A., The National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group. Live attenuated varicella vaccine: Efficacy for children with leukemia in remission. JAMA 1984;252:355–362.
6. Asano Y., Albrecht P., Vujcic L.K., Quinnan G.V.Jr., Kawakami K., Takahashi M. Five–year follow–up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membraneantigen assays. Pediatrics 1983;72:291–294
7. Gershon A.A., Steinberg S.P., Gelb L., The National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group. Live attenuated varicella vaccine use in immunocompromised children and adults. Pediatrics 1986;78(Suppl):757–762
8. Asano Y., Nagai T., Miyata T., Yazaki T., Ito S., Yamanishi K., Takahashi M. Long–term protective immunity of recipients of the OKA strain of live varicella vaccine. Pediatrics 1985;75:667–671
9. Gershon A., Steinberg S., The National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group. Persistence of immunity to varicella in leukemic children immunized with live attenuated varicella vaccine. N Engl J Med 1989;320:892–897
10. Diaz P.S., Smith S., Hunter E., Arvin A.M. Immunity to whole varicella– zoster virus antigen and glycoproteins I and pl70: Relation to the immunizing regimen of live attenuated varicella vaccine. J Infect Dis 1988;158:1245–1252
11. Williams V., Gershon A., Brunell P.A. Serologic response to varicellazoster membrane antigens measured by indirect immunofluorescence. J Infect Dis 1974;130:669–672
12. Martin J.H., Dohner D.E., Wellinghoff W.J., Gelb L.D. Restriction endonuclease analysis of varicella-zoster vaccine virus and wild–type DNAs. J Med Virol 1982;9:69–76
13. Arvin A.M., Koropchak C.M., Wittek A.E. Immunologic evidence of reinfection with varicella–zoster virus. J Infect Dis 1983;148:200–205
14. Gershon A.A., Raker R., Steinberg S., Tbpf-Olstein B., Drusin L.M. Antibody to varicella–zoster virus in parturient women and their offspring during the first year of life. Pediatrics 1976;58:692–696
15. Gershon A.A., Steinberg S. Antibody responses to varicella-zoster virus and the role of antibody in host defense. Am J Med Sci 1981;282:12–17
16. Gershon A.A., Steinberg S.P., Gelb L., The National Institute of Allergy and Infectious Diseases Collaborative Varicella Vaccine Study Group. Clinical reinfection with varicella–zoster virus. J Infect Dis 1984; 149:137–142
17. Weller T.H. Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not–so–benign virus (part 1)N Engl J Med 1983;309:1362–1368
18. Weller T.H. Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus (part 2)N Engl J Med 1983;309:1434–1440
19. Ross A., Lencher E., Reitman G. Modification of chickenpox in family contacts by administration of gamma globulin. N Engl J Med 1962; 267:369–376
20. Donowitz L.G., Hunt E.H., Pugh V.G., Farr B.M., Hendley J.O. Comparison of historical and serologic immunity to varicella–zoster virus in 373 hospital employees. Am J Infect Control 1987;15:212–214